Lasa Supergenerics Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 266.6 million compared to INR 317.05 million a year ago. Revenue was INR 266.64 million compared to INR 325.65 million a year ago. Net loss was INR 14.58 million compared to INR 49.19 million a year ago. Basic loss per share from continuing operations was INR 0.29 compared to INR 1.21 a year ago. Diluted loss per share from continuing operations was INR 0.29 compared to INR 1.21 a year ago.
For the nine months, sales was INR 815.19 million compared to INR 942.45 million a year ago. Revenue was INR 816.1 million compared to INR 951.18 million a year ago. Net loss was INR 64.31 million compared to INR 236.09 million a year ago. Basic loss per share from continuing operations was INR 1.28 compared to INR 5.8 a year ago. Diluted loss per share from continuing operations was INR 1.28 compared to INR 5.8 a year ago.